Defunct Company
Total Trials
7
As Lead Sponsor
3
As Collaborator
4
Total Enrollment
300
NCT00692926
Unrelated Umbilical Cord Blood Transplantation Augmented With ALDHbr Umbilical Cord Blood Cells
Phase: Phase 1
Role: Collaborator
Start: Oct 31, 2005
Completion: Jul 31, 2012
NCT00314366
Intramyocardial Injection of Autologous Aldehyde Dehydrogenase-Bright Stem Cells for Therapeutic Angiogenesis (FOCUS Br)
Start: Apr 30, 2006
Completion: Aug 24, 2023
NCT00392509
ALD-301 for Critical Limb Ischemia, Randomized Trial
Phase: Phase 1/2
Role: Lead Sponsor
Start: Oct 31, 2006
Completion: Dec 31, 2008
NCT00654433
ALD-101 Adjuvant Therapy of Unrelated Umbilical Cord Blood Transfusion (UCBT) in Patients With Inherited Metabolic Diseases
Phase: Phase 3
Start: Mar 31, 2008
Completion: Nov 30, 2011
NCT01003912
Fetal Umbilical Cord Blood (UCB) Transplant for Lysosomal Storage Diseases
Start: Oct 31, 2009
Completion: Mar 31, 2017
NCT01273337
Study of ALD-401 Via Intracarotid Infusion in Ischemic Stroke Subjects
Phase: Phase 2
Start: Mar 31, 2011
Completion: Jan 31, 2015
NCT01774097
Patients With Intermittent Claudication Injected With ALDH Bright Cells
Start: Jun 30, 2013